| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 03/14/2007 | CN1304371C Heterocyclically substituted benzoylureas, their pharmaceuticals and use of preparing pharmaceuticals |
| 03/13/2007 | US7189870 Cardiovascular disorders; antiinflammatory agents |
| 03/08/2007 | WO2007026962A1 Phenylene derivative |
| 03/08/2007 | WO2007025586A1 1-cycloalkyl-5-iodotetrazoles |
| 03/08/2007 | WO2007005967A3 Process for preparing valsartan |
| 03/08/2007 | US20070054947 Pharmaceutical composition comprising valsartan |
| 03/08/2007 | US20070054888 Novel substituted diamine derivatives useful as motilin agonists |
| 03/07/2007 | EP1442025B1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 03/07/2007 | EP1363915B1 Substituted calix (4) pyrroles and process for the synthesis of calix (4) pyrroles over molecular sieve catalysts |
| 03/07/2007 | CN1926118A Dimeric small molecule potentiators of apoptosis |
| 03/07/2007 | CN1923820A Novel carboxylic acid derivatives, their preparation and use |
| 03/06/2007 | US7186828 Cyclic urea compounds and preparation thereof |
| 03/06/2007 | US7186749 plasminogen activator inhibitors such as 3-phenyl-2-{[6-(5-phenyl-1H-pyrrol-2-yl)-2-naphthyl]oxy}propanoic acid, used for treating cardiovascular disorders |
| 03/06/2007 | US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders |
| 03/06/2007 | US7186725 Anti-inflammatory compositions and methods |
| 03/01/2007 | WO2007023915A1 Imprint polymer and use thereof |
| 03/01/2007 | WO2006138510B1 Substituted enaminones as nicotinic acetylcholine receptor modulators |
| 03/01/2007 | WO2006104826A3 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 03/01/2007 | US20070049584 Antiinflammatory agents, antidepressants, analgesics, purinergic receptor antagonists; neurodegenerative diseases, spinal cord injuries; 1-(2,3-dichlorophenyl)-N-[(2-methylphenyl)methyl]-1H-tetraazol-5-amine |
| 02/28/2007 | EP1756091A1 Non nucleoside reverse transcriptase inhibitors |
| 02/28/2007 | EP1755613A2 Substituted cyclic urea derivatives |
| 02/28/2007 | EP1045838B1 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid |
| 02/28/2007 | CN1922143A Alpha(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents |
| 02/28/2007 | CN1919845A Compound containing tetrazine polynitrobenzene and synthesis method thereof |
| 02/28/2007 | CN1919841A Synthetic intermediate of Irbesartan, preparation method and use thereof |
| 02/28/2007 | CN1301974C Muller Klaus-helmut |
| 02/28/2007 | CN1301964C Inhibitors of alpha 4 mediated cell adhesion |
| 02/27/2007 | US7183299 Tetrazoyl oxime derivative and agricultural chemical containing the same as active ingredient |
| 02/27/2007 | US7183279 Synergistic combinations with morphine; analgesics and cyclooxygenase-2 inhibitors, such as N-5-guanidinopentanamide-(2S)-yl-2-N-(p-hydroxyphenylacetyl)phenylenediamine and N-5-guanidinopentanamide-(2R)-yl-2-N-(p-hydroxybenzyl)-5-carboxybenzimidazole |
| 02/22/2007 | US20070043098 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides |
| 02/21/2007 | EP1753733A1 Small molecules for treatment of hypercholesterolemia and related diseases |
| 02/21/2007 | EP1551797B1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 02/21/2007 | EP1311482B1 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/21/2007 | CN1918137A Tetrazole compounds and their use as metabotropic glutamate receptor antagonists |
| 02/21/2007 | CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 02/21/2007 | CN1915964A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/20/2007 | US7179910 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors |
| 02/20/2007 | US7179825 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology |
| 02/20/2007 | US7179822 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 02/15/2007 | WO2007017897A2 Novel crystalline forms of (s)-n-(1-carboxy-2-methyl-prop-1-yl)-n-pentanoyl-n-[2'-(1h-tetrazol-5-yl)bi-phenyl-4-ylmethyl]-amine |
| 02/15/2007 | WO2007017267A2 Novel compounds |
| 02/15/2007 | US20070037752 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 02/15/2007 | CA2617289A1 Process for preparing an angiotensin ii receptor antagonist |
| 02/14/2007 | EP1751123A1 Process for preparing irbesartan |
| 02/14/2007 | EP1751108A1 Adamantyl-acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 02/14/2007 | EP1533292B1 Dibenzylamine compound and medicinal use thereof |
| 02/14/2007 | CN1914356A Surface-treating agent for metal |
| 02/14/2007 | CN1914197A Coupling reactions useful in the preparation of (1h-tetrazol-5-yl)-biphenyl derivatives |
| 02/14/2007 | CN1914192A Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
| 02/14/2007 | CN1911929A Meso position-tetra phenyl tetra phenanthro porphyrin derivetive and its preparation method |
| 02/14/2007 | CN1300143C Temozolomide refining process |
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/13/2007 | CA2122236C Quinolines and their analogs |
| 02/08/2007 | WO2007014412A1 Method for isolating 5-substituted tetrazoles |
| 02/07/2007 | EP1748992A1 Trimeric macrocyclic substituted aminoisophthalate halophenyl derivatives |
| 02/07/2007 | EP1748989A2 Aryl sulfonamides |
| 02/07/2007 | EP0971748B1 Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy |
| 02/07/2007 | CN1298721C Method of separating, large scale preparing porphyrin from complex reaction system |
| 02/07/2007 | CN1298711C Processes for producing epoxytriazole derivative and intermediate therefor |
| 02/06/2007 | US7173052 Resorcinol for lightening skin removing color |
| 02/01/2007 | WO2006132811A3 Ampa receptor potentiators |
| 02/01/2007 | WO2006127871A3 Cycloalkylidene compounds as selective estrogen receptor modulators |
| 02/01/2007 | US20070027325 Process for the preparation of cilostazol and of the intermediates thereof |
| 01/31/2007 | EP1747206A1 Amino-tetrazoles analogues and methods of use |
| 01/31/2007 | EP1747195A1 Sulfonamide compounds for the treatment of neurodegenerative disorders |
| 01/31/2007 | EP1747190A1 Process for the preparation of valsartan and precursors thereof |
| 01/30/2007 | CA2297011C Sulfonamide derivatives as therapeutic or prophylactic agent for glomerulopathy |
| 01/25/2007 | WO2007010653A1 Salt molten at room temperature and display device |
| 01/25/2007 | WO2007009638A2 Complexes containing perfluoroalkyl, method for the production and use thereof |
| 01/25/2007 | US20070021474 Heterocyclically Substituted Benzoylureas, Process For Their Preparation and Their Use as Pharmaceuticals |
| 01/25/2007 | US20070020184 Diagnostic imaging contrast agents with extended blood retention |
| 01/25/2007 | US20070020183 Perfluoroalkyl-containing complexes, process for their production as well as their use |
| 01/25/2007 | CA2615443A1 Perfluoroalkyl-containing complexes, process for their production as well as their use |
| 01/25/2007 | CA2615434A1 Perfluoroalkyl-containing complexes, process for their production as well as their use |
| 01/24/2007 | CN1901971A Cyclopropane compounds and pharmaceutical use thereof |
| 01/23/2007 | US7166593 Glucocorticoid receptor modulators |
| 01/23/2007 | CA2101104C Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumors |
| 01/18/2007 | WO2007006531A1 Metal salts of 2 ' - ( 1h-tetraz0l-5-yl) -1 . 1 ' -biphenyl-4-carboxaldehyde |
| 01/18/2007 | US20070015918 Derivatives of 1,3-diones having a herbicidal activity |
| 01/18/2007 | DE102005032209A1 New 1-cycloalkyl-5-iodotetrazole derivatives useful as microbicidal agent for the protection of plants and technical materials (e.g. wood) against infestation and/or destruction caused by microorganisms such as bacteria and fungus |
| 01/18/2007 | CA2614718A1 Metal salts of 2 ' - ( 1h-tetrazol-5-yl) -1 . 1 ' -biphenyl-4-carboxaldehyde |
| 01/17/2007 | EP1742926A1 Macrocycle-substituted trimer halogen-benzol derivatives |
| 01/17/2007 | CN1897937A 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline |
| 01/17/2007 | CN1897928A Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 01/16/2007 | US7164016 Complex containing radioactive material; medical diagnosis of tumor |
| 01/16/2007 | US7163954 Substituted naphthyl benzothiophene acids |
| 01/16/2007 | US7163942 Sulfonamide compounds for the treatment of neurodegenerative disorders |
| 01/11/2007 | WO2007005967A2 Process for preparing valsartan |
| 01/11/2007 | WO2007005845A1 Mao-b inhibitors useful for treating obesity |
| 01/11/2007 | US20070009442 Macrocyclic metal complexes and their use for the production of conjugates with biomolecules |
| 01/11/2007 | DE102005025992A1 Verfahren zur Herstellung von substituierten Azolen A process for the preparation of substituted azoles |
| 01/11/2007 | CA2616918A1 Mao-b inhibitors useful for treating obesity |
| 01/10/2007 | EP1740565A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sufide derivatives |
| 01/10/2007 | EP1740522A2 Bisphenyl compounds useful as vitamin d sb 3 /sb receptor agonists |
| 01/10/2007 | EP1153029B1 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as mri contrast agents |
| 01/10/2007 | CN1894206A N-substituted-N-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 01/10/2007 | CN1894195A Ether compounds and compositions for cholesterol management and related uses |
| 01/10/2007 | CN1894190A Method for the production of tetrahydrogeranylacetone |
| 01/09/2007 | US7160872 Methods to treat conditions mediated by chemokine receptors |
| 01/09/2007 | US7160870 Thrombopoietin mimetics |